Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 968 across all filing types
Latest filing 2025-06-25 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
关于公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company obtaining a medical device registration certificate issued by a regulatory authority (Shandong Provincial Drug Administration). It provides details about the product and its registration but does not contain financial data, management discussion, or any report-type content. The document is short (854 characters) and serves as a regulatory announcement about a certificate obtained, not a financial or management report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-25 Chinese
关于取得医疗器械注册变更文件的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (833 characters) about obtaining a medical device registration change document issued by a regulatory authority (国家药品监督管理局 - National Medical Products Administration). It details the change in product specifications and technical requirements for a medical device. The document is an official announcement of a regulatory approval or change, not a financial report or detailed filing. It does not contain financial data, management discussion, or detailed report content. It fits best as a Regulatory Filing (RNS) because it is a regulatory announcement that does not fit other specific categories like financial reports, management changes, or capital updates.
2025-06-18 Chinese
2024年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is titled '2024 年年度权益分派实施公告' which translates to '2024 Annual Dividend Distribution Implementation Announcement'. It details the dividend distribution plan approved at the 2024 Annual General Meeting, including dividend amounts, record dates, ex-dividend dates, and payment methods. The document is an announcement of the implementation of the dividend distribution, not the dividend notice itself nor a full financial report. It is relatively short (2762 characters) and focuses on the dividend payment details following shareholder approval. Therefore, it fits the category of Notice of Dividend Amount (DIV).
2025-05-20 Chinese
关于参加2025年山东辖区上市公司投资者网上集体接待日活动的公告
Regulatory Filings Classification · 95% confidence The document is an announcement about the company's participation in an investor online collective reception day event organized by regulatory and industry bodies. It mentions the date and time of the event and that company executives will communicate with investors about the 2024 annual performance, governance, strategy, and sustainability. The document is short (629 characters) and serves as a notice of an upcoming investor interaction event rather than a detailed report or transcript. It does not contain financial statements, detailed management discussion, or voting results. Therefore, it is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about investor relations activities and does not fit other specific categories like Investor Presentation or Call Transcript, which would be more detailed and substantive.
2025-05-13 Chinese
2024年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled as a "股东大会决议公告" which translates to "Shareholders' Meeting Resolution Announcement." It details the resolutions passed at the 2024 Annual General Meeting (AGM) held on May 6, 2025, including voting results on various proposals such as the board report, supervisory report, annual report, financial statements, profit distribution plan, auditor appointment, and cash management. The document includes attendance details, voting methods, and legal opinions confirming the validity of the meeting and resolutions. The content is focused on announcing the official results of shareholder votes at the AGM rather than the full AGM materials or presentations. The document length is under 5,000 characters, consistent with an announcement rather than a full report. Therefore, this document fits the category of "Declaration of Voting Results & Voting Rights Announcements" (DVA).
2025-05-06 Chinese
山东川奇律师事务所关于烟台正海生物科技股份有限公司2024年年度股东大会的法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2024 Annual General Meeting (AGM) of Yantai Zhenghai Biotechnology Co., Ltd. It details the legality of the AGM's convening, attendance, agenda, and voting procedures and results. The document does not contain the actual annual report or financial statements but rather confirms the validity and legality of the AGM process and resolutions. The document length is 4445 characters, which is relatively short and focused on the AGM event itself. This fits the description of AGM Information (AGM-R), which includes presentations and materials shared during the AGM, or related official documents about the AGM proceedings. It is not an announcement of voting results alone (DVA), as it includes legal opinions on the meeting's procedures and validity. Therefore, the best classification is AGM Information (AGM-R).
2025-05-06 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.